Plain-English translation of NCT06796725 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS) — a procedure that uses magnetic pulses to stimulate parts of your brain — guided by a special brain imaging scan called magnetoencephalography (MEG). Researchers want to see if this approach works better than a standard migraine medication called at reducing how often you get migraines, how severe they are, and how long they last. You would be randomly assigned to receive either the brain stimulation treatment or the medication.
Migraines can be disabling and hard to control with medication alone. Researchers believe that using brain imaging to guide brain stimulation might offer a new way to help people who suffer from frequent, severe migraines.
You likely qualify if…
You likely don't qualify if…
If you join the brain stimulation group, you will receive a fake stimulation during your first week (without knowing it), then receive real brain stimulation treatments over the following 4 weeks, with one treatment session scheduled each month. If you are assigned to the medication group, you will take tablets as directed and have regular follow-up visits. Throughout the study, researchers will track how often your migraines occur, how severe they are, and how much pain medication you need to use.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
Ruijin Hospital
Enrollment target
~60 participants
Started
February 2025
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
15 Years – 50 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xiaodan Wang, Doctor
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.